A case series on the use of lavendula oil capsules in patients suffering from major depressive disorder and symptoms of psychomotor agitation, insomnia and anxiety

Complementary Therapies in Medicine

Volumn 22, Issue 1, 2014, Pages 63-69

  Fißler, Maria ^a   Quante, Arnim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Agitation; Anxiety; Herbal pharmacotherapy; Insomnia; Lavendula oil; Major depressive disorder

Indexed keywords

AGITATION; ANXIETY; HERBAL PHARMACOTHERAPY; INSOMNIA; LAVENDULA OIL; MAJOR DEPRESSIVE DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OILS, VOLATILE; PLANT OILS; PSYCHOMOTOR AGITATION; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84894247357     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.11.008     Document Type: Article

References (35)

1. Andrade L., Caraveo A. Epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003, 12(1):3-21.
2. Kaufman J., Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000, 12(Suppl. 1):69-76.
3. Kessler R.C., Berglund P., Demler O. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289(203):3095-3105.
4. Psychnet-uk.com [Internet]. London: PsychNet-UK, Archan-Publishing.com; c. 1998-2012. Available from: [updated 2012 November; cited 2012 October]. http://www.psychnet-uk.com/x_new_site/DSM_IV/major_depression.html.
5. Eder C.M. Was tun bei Agitiertheit? ÖÄZ [Internet] 2006, July 15, Available from: http://www.aerztezeitung.at/archiv/oeaez-2006/oeaez-1314-15072006/agitiertheit-erste-massnahmen.html [cited 2012 October; 13/14: about 1 p., in German].
6. Hasler G., Drevets W.C., Manji H.K., Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004, 29(October (10)):1765-1781.
7. Leventhal A.M., Francione Witt C., Zimmerman M. Associations between depression subtypes and substance use disorders. Psychiatry Res 2008, 161:43-50.
8. Leventhal A.M., Gelernter J., Oslin D., Anton R.F., Farrer L.A., Kranzler H.R. Agitated depression in substance dependence. Drug Alcohol Depend 2011, 116(July (1-3)):163-169.
9. Jaret P. Depression and insomnia, 2010 July 06. In: WebMD Feature [Internet]. New York: WebMD, LLC; c. 2012, 2 pp. Available from: [cited 2012 October]. http://www.webmd.com/depression/features/sleep-problems.
10. Bolton J.M., Pagura J., Enns M.W., Grant B., Sareen J. A population-based longitudinal study of risk factors for suicide attempts in major depressive disorder. J Psychiatr Res 2010, 44(October (13)):817-826.
11. Olgiati P., Serretti A., Colombo C. Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression. Depress Anxiety 2006, 23(7):389-397.
12. Pigeon W.R., Pinquart M., Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 2012, 73(September (9)):e1160-e1167.
13. Ashton C.H. Benzodiazepines: how they work and how to withdraw. The Ashton manual [Internet] 2002, August, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, Available from: http://www.benzo.org.uk/manual/index.htm [cited 2012 October].
14. Pfeiffer P.N., Ganoczy D., Zivin K., Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. J Clin Psychopharmacol 2011, 31(June (3)):360-364.
15. Drug Monograph (Germany): Lavendulae flos. Lavendelblüten. BAnz vom 5.12.1984 und 13.03.1990.
16. Woelk H., Schlaefke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine 2010, 17:94-99.
17. European Directorate for the Quality of Medicines and Healthcare Lavender oil (Lavandulae aetheroleum) 2005, 5:1894-1895. European Directorate for Quality of Medicines and Healthcare (EDQM), Strasbourg, France.
18. Dunn C., Sleep J., Collett D. Sensing an improvement: an experimental study to evaluate the use of aromatherapy, massage and periods of rest in an intensive care unit. J Adv Nurs 1995, 2:34-40.
19. Hardy M., Kirk-Smith M.D., Stretch D.D. Replacement of drug treatment for insomnia by ambient odour. Lancet 1995, 346(September (8976)):701.
20. Itai T., Amayasu H., Kuribayashi M., Kawamura N., Okada M., Momose A., et al. Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatry Clin Neurosci 2000, 54(August (4)):393-397.
21. Wolfe N., Herzberg J. Can aromatherapy oils promote sleep in severely demented patients?. Int J Geriatr Psychiatry 1996, 11:926-927.
22. Volz H-P. Spezielles Lavendelöl für die Behandlung subsyndromaler Angststörungen. EHK 2011, 60:212-218.
23. Kasper S., Gastpar M., Müller W.E., Volz H.P., Möller H.J., Dienel A., Schläfke S. Efficacy and safety of Silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials. Wien Med Wochenschr 2010, 160(December (21-22)):547-556.
24. Kasper S., Gastpar M., Müller W.E., et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010, 25:277-287.
25. Stange R., Schaper S., Uehleke B., et al. Phase II study on the effects of lavender oil (Silexan) in patients with neurasthenia, post-traumatic stress disorders or somatisation disorder. Foc Altern Complement Ther 2007, 12(Suppl. 1):46. [Abstract].
26. ® 1265) in patients with restlessness and sleep disturbance. Annual Congress of the German Society for Psychiatry and Psychotherapy (DGPPN) 2010.
27. Diego M., Jones N., et al. Aromatherapy positively affects mood, EEG patterns of math computations. Int J Neurosci 1998, 96:217-224.
28. Field T., Cullen C., Largie S., Diego M., Schanberg S., Kuhn C. Lavender bath oil reduces stress and crying and enhances sleep in very young infants. Early Hum Dev 2008, 84(June (6)):399-401.
29. Vernet-Maury E., Alaoui-Ismaïli O., Dittmar A., Delhomme G., Chanel J. Basic emotions induced by odorants: a new approach based on autonomic pattern results. J Auton Nerv Syst 1999, 75(February (2-3)):176-183.
30. Aoshima H., Hamamoto K. Potentiation of GABA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci Biotechnol Biochem 1999, 63:743-748.
31. Chioca L.R., Ferro M.M., Baretta I.P., Oliveira S.M., Silva C.R., Ferreira J., et al. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission. J Ethnopharmacol 2013, 147(May (2)):412-418. 10.1016/j.jep.2013.03.028.
32. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
33. Dekkers O.M., Egger M., Altman D.G., Vandenbroucke J.P. Distinguishing case series from cohort studies. Ann Intern Med 2012, 156(January (1 Pt 1)):37-40.
34. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, (February (23)):56-62.
35. Hamilton M. Rating depressive patients. J Clin Psychiatry 1980, 41(12 Pt 2):21-24.